Valeant sees 'unrivaled' growth in possible Allergan merger

Mon Apr 21, 2014 5:37pm EDT

Related Topics

(Reuters) - A merger between Valeant Pharmaceuticals International Inc (VRX.TO) and Allergan Inc (AGN.N) would create an "unrivaled platform for growth and value creation" in the healthcare sector, a spokesperson for Valeant said on Monday.

Valeant will finalize and announce terms of its proposal shortly, the spokesperson said.

(Reporting by Rod Nickel. Editing by Andre Grenon)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.